ArticleInflammatory bowel diseases2026
Implementation of a Capillary Blood Self-Sampling Technique at Home for Monitoring of Patients With IBD.
Article in Inflammatory bowel diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRemote healthcare aims to improve the management of inflammatory bowel disease (IBD) patients by reducing hospital visits. This is the first study to assess capillary blood sampling at home for routine measurement of chemistry parameters and complete blood count parameters at several time points for disease monitoring in IBD patients.
methodsIn this prospective, single-center proof-of-concept study, 27 patients with Crohn's disease or ulcerative colitis and an indication for frequent blood monitoring performed capillary blood sampling in the hospital (time point 0 [T0]) and at 2 time points at home (T1 and T2). A successful at home sampling was defined as a blood sample that was (1) transported in <48 hours, (2) of sufficient quality, and (3) a sufficient volume.
resultsA total of 21 patients completed the study (mean age 31 years; 69% Crohn's disease, 31% ulcerative colitis). Seventeen (81%) out of 21 and 20 (95%) out of 21 blood samples were successfully analyzed, at T1 (between 2 and 6 weeks after T0) and T2 (between 6 and 12 weeks after T0), respectively. At T2, 12 (57%) out of 21 patients preferred capillary blood sampling at home over venous sampling at the hospital. Younger patients expressed higher satisfaction rates. Fifteen (71%) out of 21 patients reported a better performance with blood sampling at T2 compared with T1.
conclusionsThis study shows a high success rate for capillary blood sampling at home for routine disease monitoring in IBD patients. Device optimization and identification of patient preferences are needed to effectively integrate blood sampling at home in remote monitoring of IBD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.